Literature DB >> 11793439

Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma.

David Gisselsson1, Eva Pålsson, Mattias Höglund, Henryk Domanski, Fredrik Mertens, Nikos Pandis, Raf Sciot, Paola Dal Cin, Julia A Bridge, Nils Mandahl.   

Abstract

Most osteosarcomas are highly aggressive malignancies characterized by a complex pattern of chromosome abnormalities. However, a subgroup of low-grade, parosteal tumors exhibits a relatively simple aberration pattern dominated by ring chromosomes carrying amplified material from chromosome 12. To assess whether sequences from this chromosome were differentially amplified in low- and high-grade osteosarcomas, copy numbers of the CCND2, ETV6, KRAS2, and D12S85 regions in 12p and the MDM2 region in 12q were evaluated by interphase or metaphase fluorescence in situ hybridization (FISH) in 24 osteosarcomas. Amplification of MDM2 was detected in all five low-grade and four high-grade osteosarcomas, all of which showed ring chromosomes. An overrepresentation of 12p sequences was found in 1/5 low-grade and in 9/19 high-grade tumors. Multicolor single-copy FISH analysis of metaphase cells from six high-grade tumors showed that extra 12p material either occurred together with MDM2 in ring chromosomes or was scattered over the genome as a result of complex structural rearrangements. Most tumors (8/10) not containing amplification of the assessed chromosome 12 loci exhibited a nondiploid pattern at evaluation with probes for centromeric alpha satellite sequences. These findings indicate that gain of sequences from the short arm of chromosome 12 could be a possible genetic pathway in the development of aggressive osteosarcoma. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11793439     DOI: 10.1002/gcc.1219

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  13 in total

1.  Parosteal osteogenic sarcoma: treatment by block resection. Everett J. Gordon MD CORR 1959;14:171-178.

Authors:  Richard A Brand
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

Review 2.  Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.

Authors:  Valerie B Sampson; Davida F Kamara; E Anders Kolb
Journal:  Expert Opin Drug Discov       Date:  2013-07-12       Impact factor: 6.098

3.  Chromosome 2 (2p16) abnormalities in Carney complex tumours.

Authors:  L Matyakhina; S Pack; L S Kirschner; E Pak; P Mannan; J Jaikumar; S E Taymans; F Sandrini; J A Carney; C A Stratakis
Journal:  J Med Genet       Date:  2003-04       Impact factor: 6.318

4.  The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.

Authors:  Abberly Lott Limbach; Mark W Lingen; James McElherne; Heather Mashek; Carrie Fitzpatrick; Elizabeth Hyjek; Reza Mostofi; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2020-02-05

5.  Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.

Authors:  Hiroaki Kimura; Yoh Dobashi; Takayuki Nojima; Hiroyuki Nakamura; Norio Yamamoto; Hiroyuki Tsuchiya; Hiroko Ikeda; Seiko Sawada-Kitamura; Takeru Oyama; Akishi Ooi
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

6.  Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature.

Authors:  Renaud Sabatier; Corinne Bouvier; Gonzague de Pinieux; Anthony Sarran; Isabelle Brenot-Rossi; Florence Pedeutour; Bruno Chetaille; Patrice Viens; Pierre-Jean Weiller; François Bertucci
Journal:  BMC Cancer       Date:  2010-11-24       Impact factor: 4.430

Review 7.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

Review 8.  Sex chromosome evolution in amniotes: applications for bacterial artificial chromosome libraries.

Authors:  Daniel E Janes; Nicole Valenzuela; Tariq Ezaz; Chris Amemiya; Scott V Edwards
Journal:  J Biomed Biotechnol       Date:  2010-10-12

9.  Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation.

Authors:  Naoko Kudo; Akira Ogose; Tetsuo Hotta; Hiroyuki Kawashima; Wenguang Gu; Hajime Umezu; Tsuyoshi Toyama; Naoto Endo
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.535

10.  Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.

Authors:  Tsz-Kwong Man; Xin-Yan Lu; Kim Jaeweon; Laszlo Perlaky; Charles P Harris; Shishir Shah; Marc Ladanyi; Richard Gorlick; Ching C Lau; Pulivarthi H Rao
Journal:  BMC Cancer       Date:  2004-08-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.